Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on May 21, 2026

Licensing Expo Concludes with Record-Breaking Show Floor and Participation from Cultural Icons, Cementing Status as Global Epicenter for Brand Collaboration
VVC Exploration Corporation Provides Regulatory Update and Clarifies a Previous Incorrect Statement about CYRB
IDX Insights Launches Illumyn Guardian, a Next-Generation Platform for Biblical Responsible Investing
ATEC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alphatec Holdings, Inc.
GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc.
POET SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of POET Technologies Inc. Investors - Contact Kirby McInerney LLP by June 29, 2026
Audiencerate: Riccardo Fabbri wird Chief Technology Officer. Die KI-gesteuerte Phase der Plattformen für KMU und Medienagenturen beginnt
Audiencerate : Riccardo Fabbri rejoint l’équipe en tant que directeur technique. Début de la phase pilotée par l’IA des plateformes pour PME et agences médias
Prolific Evolutions Celebrates Career Growth Through Multiple Management Expansions
Midland Exploration Completes a $5.3 Million Private Placement
Exploration Midland complète un placement privé de 5,3 millions $
Uplink Launches Live Connectivity Marketplace for Wi-Fi Offload to Accelerate OpenRoaming and Neutral Host Monetisation
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
Samba TV Launches Project Gravity, an Independent Data Activation Platform for the Agentic Era
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma
Modaxo Enters into Agreement to Acquire the Public Transit Business from Conduent
nVent to Participate in Upcoming Investor Conference
Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Telecoms Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.